Nobuhiko Hasegawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
DNA demethylating agents suppress preclinical models of synovial sarcoma.
Journal: The Journal of clinical investigation
Published: January 03, 2025
Potential Involvement of Myostatin in Smooth Muscle Differentiation in Pleomorphic Leiomyosarcoma.
Journal: International journal of molecular sciences
Published: December 31, 2024
Non-metastatic hip fractures surgery in patients with active cancer: benefit and risk.
Journal: International orthopaedics
Published: January 15, 2024
NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts.
Journal: Scientific reports
Published: June 26, 2023
Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Journal: Clinical orthopaedics and related research
Published: March 28, 2023
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma.
Journal: Technology in cancer research & treatment
Published: December 08, 2022
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: March 25, 2022
Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma.
Journal: Virchows Archiv : an international journal of pathology
Published: February 16, 2022
IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: October 14, 2021
Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Journal: Cancer science
Published: May 27, 2021
Last Updated: 09/26/2026